CRP and hepatocellular carcinoma: The CRAFITY score based on serum C-reactive protein (CRP) and alpha-fetoprotein (AFP) levels is an easy-to-apply prognostic score for HCC patients treated with anti-PD-1-based immunotherapy (10).